Anebulo Pharmaceuticals, Inc. (ANEB) vs Pasithea Therapeutics Corp. (KTTA)

Anebulo Pharmaceuticals, Inc. and Pasithea Therapeutics Corp. are both Biotechnology companies. Anebulo Pharmaceuticals, Inc. and Pasithea Therapeutics Corp. are of similar size ($17.6M and $17.2M). Across the 9 metrics below, Pasithea Therapeutics Corp. leads on 5 and Anebulo Pharmaceuticals, Inc. on 4.

Valuation

Metric ANEB KTTA Biotechnology median
P/E n/m n/m 7.88
P/S n/m 32.98 11.47
P/B 1.71 0.32 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 1.28 0.74
EV/Sales n/m (61.07) 10.73
Earnings yield (57.58%) (316.00%) (28.84%)
Free cash flow yield (43.08%) (109.92%) (23.03%)

Profitability

Metric ANEB KTTA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (69.69%) (65.49%) (57.72%)
Return on assets (63.17%) (61.97%) (49.22%)
Return on invested capital 0.00% (367.46%) 0.00%

Growth

Metric ANEB KTTA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 21.88% 77.07% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANEB KTTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.24 26.25 4.73
Net debt to EBITDA 1.32 2.74 0.96

Dividend

Metric ANEB KTTA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ANEB KTTA Biotechnology median
Market cap 17.60m 17.17m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack